HHS · Harte Hanks Inc
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Customer Care segment revenue | $12.85M | FY2026 Q2 | +8.5% |
|
|
|||
| Fulfillment & Logistics Services segment revenue | $17.61M | FY2026 Q2 | -2.8% |
|
|
|||
| Adjusted EBITDA non-GAAP | $0.7M | Q1 2026 | — |
|
|
|||
| Customer Care segment EBITDA | $1.5M | Q4 2025 | — |
| Employee count | 2,100 | FY2025 | — |
| Fulfillment & Logistics Services segment EBITDA | $1.1M | Q4 2025 | — |
| Revenue Solutions segment EBITDA | $1.4M | Q4 2025 | — |
| Revenue Solutions segment revenue | $8.9M | Q4 2025 | -21.5% |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Conglomerates — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HHS
this stock
Harte Hanks Inc
|
$31.90M | +42.9% | -13.9% | — | 0.2% |
|
HTHIY
Hitachi Ltd
|
$163.40B | +15.9% | — | — | 0.0% |
|
MMM
3M Co
|
$94.20B | +14.1% | +1.5% | 32.4 | 1.9% |
|
ITOCF
Itochu Corp
|
$88.07B | -0.4% | — | — | 0.1% |
|
HON
Honeywell International Inc
|
$74.15B | — | +12.9% | — | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HHS | +88.6% | +79.9% | +46.8% | +96.4% | +42.9% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +88.2% | +75.5% | +33.0% | +92.4% | +29.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.